Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence

被引:22
|
作者
Gliklich, Richard E. [1 ,2 ]
Leavy, Michelle B. [1 ]
机构
[1] OMI Inc, 800 Boylston St,Suite 1410, Boston, MA 02199 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
关键词
21st Century Cures Act; medical product evaluation; electronic health records; product registries; disease registries; TASK-FORCE; GUIDELINES; CHECKLIST;
D O I
10.1007/s43441-019-00058-6
中图分类号
R-058 [];
学科分类号
摘要
The use of real-world data and real-world evidence to inform health care decisions is increasing. Yet, the variable quality of these data and the lack of widely-accepted criteria by which to assess quality create uncertainty about how and when to use these data and the associated evidence in decision making. Patient registries are an important source of real-world data and real-world evidence. The good practices and evaluation criteria developed for patient registries are highly relevant to real-world data and real-world evidence and offer a foundation for a unified set of quality criteria that can be applied across sources of real-world data and real-world evidence intended for use in medical product evaluation.
引用
收藏
页码:303 / 307
页数:5
相关论文
共 50 条
  • [1] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
    Richard E. Gliklich
    Michelle B. Leavy
    [J]. Therapeutic Innovation & Regulatory Science, 2020, 54 : 303 - 307
  • [2] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    [J]. TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [3] Translating real-world evidence/real-world data
    Ravenstijn, Paulien
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
  • [4] ASSESSING THE QUALITY OF REAL-WORLD DATA AND REAL-WORLD EVIDENCE IN ONCOLOGY RESEARCH: A COHESIVE FRAMEWORK FOR RESEARCHERS
    Su, Z.
    Dye, J.
    Wilson, T.
    Amirian, E. S.
    O'Sullivan, A.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S377 - S377
  • [5] Real-World Battles with Real-World Data
    Brown, Jeffrey
    Bate, Andrew
    Platt, Robert
    Raebel, Marsha
    Sauer, Brian
    Trifiro, Gianluca
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 254 - 255
  • [6] Data Science Methods for Real-World Evidence Generation in Real-World Data
    Liu, Fang
    [J]. ANNUAL REVIEW OF BIOMEDICAL DATA SCIENCE, 2024, 7 : 201 - 224
  • [7] REAL-WORLD PROBLEMS WITH REAL-WORLD DATA: ADDRESSING DATA QUALITY IN THE ELECTRONIC HEALTH RECORD
    Anderson, Wesley
    Boyce, Danielle
    Kurtycz, Ruth
    Roddy, Will
    Heavner, Smith
    [J]. CRITICAL CARE MEDICINE, 2024, 52
  • [8] Editorial: Real-world data and real-world evidence in lung cancer
    Gristina, Valerio
    Eze, Chukwuka
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [9] Editorial: Real-world data and real-world evidence in hematologic malignancies
    Malagola, Michele
    Ohgami, Robert
    Greco, Raffaella
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [10] When can real-world data generate real-world evidence?
    Rahman, Motiur
    Dal Pan, Gerald
    Stein, Peter
    Levenson, Mark
    Kraus, Stefanie
    Chakravarty, Aloka
    Rivera, Donna R.
    Forshee, Richard
    Concato, John
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)